Inanovate is a medical device-diagnostics company that has developed a breakthrough proteomics platform technology called Longitudinal Assay Screening (LAS) for screening and analyzing proteins. Their flagship product, the Bio-ID, integrates LAS for the detection and measurement of multiple proteins. Inanovate focuses on providing solutions for the Life Sciences industry by offering innovative technology for protein interactions and biomarker discovery. They have established alliance partnerships with renowned institutions like Harvard Medical School and Brigham & Women’s Hospital for research on protein biomarkers. Inanovate's mission is to offer a complete solution for multiple protein detection and measurement, addressing the challenges faced by researchers and clinicians in the field.